← Ginkgo Bioworks Holdings, Inc.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | $380.8m | $1.6b | $1.3b | $944.1m | $561.6m | $167.2m | |
| Accounts receivable, net | $16.7m | $131.5m | $80.9m | $17.2m | $21.9m | $24.0m | |
| Accounts receivable - related parties | $5.2m | $4.6m | $1.6m | $742k | $586k | $229k | |
| Prepaid expenses and other current assets | $21.1m | $33.5m | $47.5m | $39.8m | $18.7m | $25.0m | |
| Total current assets | $426.5m | $1.7b | $1.5b | $1.0b | $602.7m | $471.8m | |
| Property, plant and equipment, net | $121.4m | $145.8m | $314.8m | $188.2m | $203.7m | $167.8m | |
| Intangible assets, net | $3.3m | $21.6m | $111.0m | $82.7m | $72.5m | $56.9m | |
| Operating lease right-of-use assets | — | $0 | $400.8m | $206.8m | $394.4m | $360.9m | |
| Marketable securities | — | — | — | — | $0 | $255.4m | |
| Investments | $74.2m | $102.0m | $112.2m | $78.6m | $48.7m | $15.1m | |
| Other non-current assets | $5.6m | $44.0m | $88.7m | $58.1m | $55.3m | $47.2m | |
| Deferred revenue (includes $98 and $795 from related parties) | $28.8m | $33.2m | $47.8m | $44.5m | $27.7m | $18.9m | |
| Accrued expenses and other current liabilities | $30.5m | $93.3m | $114.7m | $110.1m | $65.4m | $66.5m | |
| Operating lease liabilities, non-current | — | $0 | $413.3m | $221.8m | $438.8m | $417.1m | |
| Other non-current liabilities | $3.0m | $36.0m | $31.2m | $18.7m | $16.6m | $22.9m | |
| Total stockholders’ equity | $470.1m | $1.6b | $1.7b | $1.1b | $716.1m | $508.6m | |
| Total assets | $675.2m | $2.1b | $2.5b | $1.7b | $1.4b | $1.1b | |
| Total liabilities and stockholders’ equity | $675.2m | $2.1b | $2.5b | $1.7b | $1.4b | $1.1b | |
| Accounts payable | $13.9m | $8.2m | $10.5m | $9.3m | $14.2m | $10.6m | |
| Deferred revenue, net of current portion (includes $64,787 and $72,260 from related parties) | $99.7m | $156.0m | $174.8m | $158.1m | $98.8m | $75.2m | |
| Total current liabilities | $73.2m | $134.8m | $173.0m | $163.9m | $107.3m | $96.0m | |
| Total liabilities | $205.1m | $503.6m | $803.0m | $568.2m | $661.4m | $611.1m | |
| Preferred stock, $0.0001 par value; 200,000,000 shares authorized; none issued | $0 | $0 | $0 | $0 | $0 | $0 | |
| Common stock, $0.0001 par value (Note 13) | $129k | $161k | $190k | $199k | $5k | $6k | |
| Additional paid-in capital | $929.1m | $3.8b | $6.1b | $6.4b | $6.6b | $6.7b | |
| Accumulated deficit | ($467.9m) | ($2.3b) | ($4.4b) | ($5.3b) | ($5.8b) | ($6.2b) | |
| Accumulated other comprehensive income (loss) | $0 | ($1.7m) | ($2.6m) | $1.5m | ($1.8m) | $1.9m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.